Recombinant TSH Stimulated Remnant Ablation Therapy in Thyroid Cancer: The Success Rate Depends on the Definition of Ablation Success—An Observational Study

INTRODUCTION: Patients with differentiated thyroid cancer (DTC) are treated with (near)-total thyroidectomy followed by remnant ablation. Optimal radioiodine-131 ((131)I) uptake is achieved by withholding thyroid hormone (THW), pretreatment with recombinant human Thyrotropin Stimulating Hormone (rhT...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: van der Horst-Schrivers, Anouk N. A., Sluiter, Wim J., Muller Kobold, Anneke C., Wolffenbuttel, Bruce H. R., Plukker, John T. M., Bisschop, Peter H., de Klerk, John M., Al Younis, Imad, Lips, Paul, Smit, Jan W., Brouwers, Adrienne H., Links, Thera P.
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367989/
https://ncbi.nlm.nih.gov/pubmed/25793762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0120184
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars